Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 14/74 ]
NASDAQ | Common Stock
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China.
Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.
The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons.
NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Oct 24, 24 | -0.75 Decreased by -259.06% | - |
| Aug 6, 24 | -0.74 Decreased by -281.43% | - |
| May 15, 24 | -1.67 Decreased by -735.75% | - |
| Feb 22, 24 | -1.08 Decreased by -1.10 K% | - |
| Oct 26, 23 | -0.21 Increased by +9.74% | - |
| Jul 27, 23 | -0.19 Decreased by -14.65% | - |
| May 3, 23 | -0.20 Increased by +82.14% | - |
| Feb 23, 23 | -0.09 Increased by +92.50% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 587.31 K Decreased by -51.19% | -1.51 M Increased by +14.73% | Decreased by -256.80% Decreased by -74.69% |
| Jun 30, 24 | 769.15 K Decreased by -53.55% | -1.49 M Increased by +3.19% | Decreased by -193.45% Decreased by -108.39% |
| Mar 31, 24 | 1.09 M Decreased by -36.60% | -3.03 M Decreased by -110.64% | Decreased by -277.04% Decreased by -232.22% |
| Dec 31, 23 | 1.32 M Decreased by -28.67% | -1.65 M Decreased by -141.99% | Decreased by -125.18% Decreased by -239.26% |
| Sep 30, 23 | 1.20 M Decreased by -38.86% | -1.77 M Decreased by -17.95% | Decreased by -147.01% Decreased by -92.94% |
| Jun 30, 23 | 1.66 M Decreased by -22.57% | -1.54 M Decreased by -38.53% | Decreased by -92.83% Decreased by -78.90% |
| Mar 31, 23 | 1.72 M Decreased by -25.09% | -1.44 M Decreased by -50.58% | Decreased by -83.39% Decreased by -101.01% |
| Dec 31, 22 | 1.85 M Increased by +1.50% | -681.65 K Increased by +32.04% | Decreased by -36.90% Increased by +33.04% |